Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

YmAbs

YmAbs?uq=kzBhZRuG
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$80M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of cancer treatments through immunotherapies created to drive multiple product candidates in select solid tumor cancers to FDA approval. The company's lead antibody programs target GD2 and B7-H3 and utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies, enabling doctors to reduce longer-term toxicities associated with current chemotherapeutics and provide the potential for curative therapy even for patients with widespread disease.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 750 Third Avenue, 9th Floor
  • New York, NY 10017
  • United States

+1 (212) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore YmAbs’s full profile, request a free trial.

YmAbs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 29-Nov-2017 $80M 00000 Completed Clinical Trials - General
3. Angel (individual) 09-Jan-2017 0000 0000 Completed Clinical Trials - General
2. Seed Round 09-Aug-2016 $15M $25M Completed Clinical Trials - General
1. Seed Round 08-Jan-2016 $10M $10M Completed Clinical Trials - General
To view this company’s complete deal history including valuation and funding, request access »

YmAbs Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0
Scopia Asset Manager Minority 000 0000 000000 0
Sofinnova Ventures Venture Capital Minority 000 0000 000000 0

YmAbs Executive Team (5)

Name Title Board
Seat
Contact
Info
Claus Moller Ph.D Chief Executive Officer
Thomas Gad President, Head of Business Development & Strategy, Chairman and Founder
Bo Kruse Chief Financial Officer, Treasurer, Secretary and Board Member
Torben Lund-Hansen Ph.D Senior Vice President, Head of Technical Operations and Board Member
Steen Lisby MD Chief Medical Officer & Senior Vice President

YmAbs Board Members (2)

Name Representing Role Since Contact
Info
Gregory Raskin MD Self Board Member 000 0000
Johan Wedell-Wedellsborg Self Board Member 000 0000